US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Oragenics

0.4985

-0.0076-1.50%

Post-market: 0.4981-0.0004-0.08%17:10 EDT

Volume:22.88K

Turnover:11.51K

Market Cap:2.25M

PE:-0.14

High:0.5234

Open:0.5061

Low:0.4960

Close:0.5061

52wk High:1.45

52wk Low:0.4801

Shares:4.51M

Float Shares:4.41M

Volume Ratio:0.46

T/O Rate:0.52%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.5875

EPS(LYR):-4.5629

ROE:-1307.06%

ROA:-171.49%

PB:0.61

PE(LYR):-0.11

Loading ...

Overview Company News Filings

Oragenics Inc - to Issue 3.25 Mln Restricted Preferred Shares to Sigyn, Convertible One-to-One

THOMSON REUTERS

BRIEF-Oragenics Inc - Signs Letter Of Intent To License Cardiodialysis From Sigyn Therapeutics - SEC Filing

Oragenics Inc - Signs Letter of Intent to License Cardiodialysis From Sigyn Therapeutics - SEC Filing

THOMSON REUTERS

Oragenics Inc - to Receive Exclusive License for Cardiodialysis for Tbi and Neurodegenerative Diseases - SEC Filing

THOMSON REUTERS

Oragenics signs LOI to license Sigyn CardioDialysis technology for TBI treatment

Oragenics Activates Second Site In Phase Iia Clinical Trial Of Onp-002 For Concussion And Mild Traumatic Brain Injury.

Oragenics activates second site for Phase IIa ONP-002 concussion trial in Australia

Oragenics Inc: Phase Iia Clinical Data Readout Is Projected Before Year-End 2026

THOMSON REUTERS

Oragenics announces 8 drug doses administered in Phase IIa trial of ONP-002

Oragenics doses 2 patients in Phase IIa ONP-002 concussion trial

Oragenics Reports 8 Study Drug Doses in Phase Iia Clinical Trial of Onp-002 for Mild Traumatic Brain Injury

THOMSON REUTERS

Oragenics doses first patient in Phase IIa ONP-002 concussion trial

Oragenics Sets New 2025 Annual Shareholder Meeting Date

Oragenics changes annual shareholder meeting date to late June 2026

Oragenics receives audit opinion with going concern explanation

Oragenics, Inc. Receives Audit Opinion with Going Concern Explanation

Oragenics files annual report on Form 10-K

Oragenics FY 2025 net loss narrows 6.86% to USD 9.84 million

Oragenics completes first Phase IIa ONP-002 trial site initiation visit in Australia

Oragenics Initiates Phase Iia Clinical Trial Site Activation

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/OGEN/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OGEN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OGEN\",,,,,undefined,":{"symbol":"OGEN","market":"US","secType":"STK","nameCN":"Oragenics","latestPrice":0.4985,"timestamp":1788465600000,"preClose":0.5061,"halted":0,"volume":22875,"hourTrading":{"tag":"盘后","latestPrice":0.4981,"preClose":0.4985,"latestTime":"17:10 EDT","volume":23,"amount":11.4510997,"timestamp":1788469834532,"change":-0.0004,"changeRate":-0.000802,"amplitude":0.001404},"delay":0,"changeRate":-0.015016795099782643,"floatShares":4409920,"shares":4512000,"eps":-3.5875,"marketStatus":"Post-Mkt","change":-0.0076,"latestTime":"09-03 18:47:04 EDT","open":0.5061,"high":0.5234,"low":0.496,"amount":11505.5028,"amplitude":0.054139,"askPrice":0.5724,"askSize":100,"bidPrice":0.485,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-3.5875,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788480000000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"AMEX","adjPreClose":0.5061,"preHourTrading":{"tag":"盘前","latestPrice":0.5061,"preClose":0.5061,"latestTime":"09:14 EDT","volume":506,"amount":256.1470164,"timestamp":1788441246972,"change":0,"changeRate":0,"amplitude":0.059672},"postHourTrading":{"tag":"盘后","latestPrice":0.4981,"preClose":0.4985,"latestTime":"17:10 EDT","volume":23,"amount":11.4510997,"timestamp":1788469834532,"change":-0.0004,"changeRate":-0.000802,"amplitude":0.001404},"volumeRatio":0.461403},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OGEN\",,,,,undefined,":{"symbol":"OGEN","floatShares":4409920,"roa":"-171.49%","roe":"-1307.06%","lyrEps":-4.562883,"volumeRatio":0.461403,"shares":4512000,"dividePrice":0,"high":0.5234,"amplitude":0.054139,"preClose":0.5061,"low":0.496,"week52Low":0.4801,"pbRate":"0.61","week52High":1.45,"institutionHeld":0.0164,"latestPrice":0.4985,"committee":0.333333,"eps":-3.5875,"divideRate":0,"volume":22875,"delay":0,"ttmEps":-3.5875,"open":0.5061,"prevYearClose":0.7832,"prevWeekClose":0.5242,"prevMonthClose":0.5098,"prevQuarterClose":0.5806,"fiveDayClose":0.532,"twentyDayClose":0.5435,"sixtyDayClose":0.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OGEN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"OGEN","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-0.57},{"market":"US","date":"2026-05-08","symbol":"OGEN","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778212800000,"reportTimeType":"post","actualEps":-0.51},{"market":"US","date":"2026-03-16","symbol":"OGEN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773633600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-11-07","symbol":"OGEN","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762491600000,"reportTimeType":"post","actualEps":-1.96},{"market":"US","date":"2025-08-08","symbol":"OGEN","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754625600000,"reportTimeType":"post","actualEps":-3.1}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OGEN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OGEN\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/OGEN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"OGEN","date":"2026-09-02","current":-0.138955,"percent":0.879282,"low":-4.718144,"twenty":-1.980415,"median":-0.49881,"eighty":-0.260612,"high":-0.09267,"avg":-1.029142,"sd":1.083878,"marketCap":2251466},"quantilePoints":[{"date":"2021-09-03","current":-4.663093,"twenty":-3.060977,"median":-1.9793,"eighty":-1.41681,"marketCap":83660254},{"date":"2021-09-10","current":-4.418281,"twenty":-3.069641,"median":-1.9793,"eighty":-1.41681,"marketCap":79268090},{"date":"2021-09-17","current":-4.127485,"twenty":-3.081975,"median":-1.9793,"eighty":-1.41681,"marketCap":74050944},{"date":"2021-09-24","current":-4.087331,"twenty":-3.097072,"median":-1.9793,"eighty":-1.41681,"marketCap":73330536},{"date":"2021-10-01","current":-4.09316,"twenty":-3.107478,"median":-1.9793,"eighty":-1.41681,"marketCap":73435111},{"date":"2021-10-08","current":-3.771924,"twenty":-3.115699,"median":-1.9793,"eighty":-1.41681,"marketCap":67671849},{"date":"2021-10-15","current":-3.860161,"twenty":-3.116763,"median":-1.9793,"eighty":-1.41681,"marketCap":69254892},{"date":"2021-10-22","current":-3.771928,"twenty":-3.127744,"median":-1.9793,"eighty":-1.41681,"marketCap":67671923},{"date":"2021-10-29","current":-4.16573,"twenty":-3.141626,"median":-1.9793,"eighty":-1.41681,"marketCap":74737086},{"date":"2021-11-05","current":-4.111882,"twenty":-3.156665,"median":-1.985326,"eighty":-1.41681,"marketCap":73771009},{"date":"2021-11-12","current":-4.001592,"twenty":-3.167278,"median":-1.989255,"eighty":-1.41681,"marketCap":71792298},{"date":"2021-11-19","current":-3.62605,"twenty":-3.174744,"median":-1.991329,"eighty":-1.41681,"marketCap":64645658},{"date":"2021-11-26","current":-3.590142,"twenty":-3.174744,"median":-1.991329,"eighty":-1.41681,"marketCap":64005487},{"date":"2021-12-03","current":-3.246079,"twenty":-3.189974,"median":-1.991329,"eighty":-1.41681,"marketCap":57871482},{"date":"2021-12-10","current":-3.197113,"twenty":-3.199072,"median":-1.991329,"eighty":-1.41681,"marketCap":56998521},{"date":"2021-12-17","current":-3.133785,"twenty":-3.199072,"median":-1.991329,"eighty":-1.41681,"marketCap":55869492},{"date":"2021-12-23","current":-3.147495,"twenty":-3.205946,"median":-1.991329,"eighty":-1.41681,"marketCap":56113921},{"date":"2021-12-31","current":-2.911808,"twenty":-3.205946,"median":-1.991329,"eighty":-1.41681,"marketCap":51912069},{"date":"2022-01-07","current":-3.41909,"twenty":-3.210206,"median":-1.992158,"eighty":-1.418244,"marketCap":60955944},{"date":"2022-01-14","current":-3.069803,"twenty":-3.219069,"median":-1.992158,"eighty":-1.418244,"marketCap":54728823},{"date":"2022-01-21","current":-3.00321,"twenty":-3.219069,"median":-1.992158,"eighty":-1.418244,"marketCap":53541596},{"date":"2022-01-28","current":-2.66437,"twenty":-3.219069,"median":-1.992158,"eighty":-1.418244,"marketCap":47500707},{"date":"2022-02-04","current":-2.742062,"twenty":-3.219069,"median":-1.992158,"eighty":-1.418244,"marketCap":48885805},{"date":"2022-02-11","current":-2.623892,"twenty":-3.209927,"median":-1.992158,"eighty":-1.418244,"marketCap":46779060},{"date":"2022-02-18","current":-2.560563,"twenty":-3.209927,"median":-1.992158,"eighty":-1.418244,"marketCap":45650030},{"date":"2022-02-25","current":-2.415626,"twenty":-3.209927,"median":-1.992158,"eighty":-1.418244,"marketCap":43066066},{"date":"2022-03-04","current":-2.154477,"twenty":-3.209927,"median":-1.992158,"eighty":-1.418244,"marketCap":38410275},{"date":"2022-03-11","current":-2.324876,"twenty":-3.209927,"median":-1.992158,"eighty":-1.418244,"marketCap":41448179},{"date":"2022-03-18","current":-2.29158,"twenty":-3.209927,"median":-1.995269,"eighty":-1.418244,"marketCap":40854565},{"date":"2022-03-25","current":-2.518788,"twenty":-3.209927,"median":-2.00103,"eighty":-1.418244,"marketCap":39574223},{"date":"2022-04-01","current":-2.500267,"twenty":-3.209927,"median":-2.010296,"eighty":-1.418244,"marketCap":39283236},{"date":"2022-04-08","current":-2.727699,"twenty":-3.209927,"median":-2.017252,"eighty":-1.418244,"marketCap":42856556},{"date":"2022-04-14","current":-2.577313,"twenty":-3.209927,"median":-2.024354,"eighty":-1.418244,"marketCap":40493742},{"date":"2022-04-22","current":-2.628429,"twenty":-3.209927,"median":-2.033014,"eighty":-1.418244,"marketCap":41296866},{"date":"2022-04-29","current":-2.446928,"twenty":-3.209927,"median":-2.052993,"eighty":-1.420185,"marketCap":38445193},{"date":"2022-05-06","current":-2.282466,"twenty":-3.209927,"median":-2.065281,"eighty":-1.420185,"marketCap":35861229},{"date":"2022-05-13","current":-1.89448,"twenty":-3.209927,"median":-2.065281,"eighty":-1.420185,"marketCap":31310193},{"date":"2022-05-20","current":-1.999416,"twenty":-3.209927,"median":-2.065281,"eighty":-1.420185,"marketCap":33044476},{"date":"2022-05-27","current":-2.324788,"twenty":-3.209927,"median":-2.074471,"eighty":-1.420185,"marketCap":38421914},{"date":"2022-06-03","current":-2.288166,"twenty":-3.209927,"median":-2.121217,"eighty":-1.420185,"marketCap":37816662},{"date":"2022-06-10","current":-2.22619,"twenty":-3.209927,"median":-2.15908,"eighty":-1.420185,"marketCap":36792388},{"date":"2022-06-17","current":-2.253657,"twenty":-3.209927,"median":-2.166396,"eighty":-1.420713,"marketCap":37246327},{"date":"2022-06-24","current":-2.253657,"twenty":-3.209931,"median":-2.185028,"eighty":-1.422926,"marketCap":37246327},{"date":"2022-07-01","current":-2.354367,"twenty":-3.209931,"median":-2.212809,"eighty":-1.422926,"marketCap":38910773},{"date":"2022-07-08","current":-2.507897,"twenty":-3.209931,"median":-2.220842,"eighty":-1.422926,"marketCap":41448179},{"date":"2022-07-15","current":-2.434654,"twenty":-3.209931,"median":-2.23863,"eighty":-1.422926,"marketCap":40237673},{"date":"2022-07-22","current":-2.376199,"twenty":-3.209931,"median":-2.253488,"eighty":-1.422926,"marketCap":39271596},{"date":"2022-07-29","current":-2.508602,"twenty":-3.209931,"median":-2.267742,"eighty":-1.422926,"marketCap":41459818},{"date":"2022-08-05","current":-2.605791,"twenty":-3.209931,"median":-2.285704,"eighty":-1.422926,"marketCap":43066066},{"date":"2022-08-12","current":-2.612284,"twenty":-3.209931,"median":-2.289008,"eighty":-1.427633,"marketCap":43741156},{"date":"2022-08-19","current":-2.662333,"twenty":-3.209931,"median":-2.289008,"eighty":-1.427633,"marketCap":44579198},{"date":"2022-08-26","current":-2.293916,"twenty":-3.209931,"median":-2.293916,"eighty":-1.427633,"marketCap":38410275},{"date":"2022-09-02","current":-1.964427,"twenty":-3.209931,"median":-2.28887,"eighty":-1.427633,"marketCap":32893162},{"date":"2022-09-09","current":-1.946353,"twenty":-3.209931,"median":-2.278604,"eighty":-1.427633,"marketCap":32590536},{"date":"2022-09-16","current":-2.255685,"twenty":-3.209931,"median":-2.255685,"eighty":-1.427633,"marketCap":37770104},{"date":"2022-09-23","current":-1.59879,"twenty":-3.206542,"median":-2.252011,"eighty":-1.427633,"marketCap":26770797},{"date":"2022-09-30","current":-1.577936,"twenty":-3.197753,"median":-2.237392,"eighty":-1.427633,"marketCap":26421613},{"date":"2022-10-07","current":-1.599485,"twenty":-3.189974,"median":-2.220417,"eighty":-1.427633,"marketCap":26782436},{"date":"2022-10-14","current":-1.54318,"twenty":-3.189974,"median":-2.195202,"eighty":-1.427633,"marketCap":25839639},{"date":"2022-10-21","current":-1.484094,"twenty":-3.189974,"median":-2.173713,"eighty":-1.427633,"marketCap":24850283},{"date":"2022-10-28","current":-1.453509,"twenty":-3.189974,"median":-2.121833,"eighty":-1.427633,"marketCap":24338146},{"date":"2022-11-04","current":-1.379404,"twenty":-3.189974,"median":-2.109082,"eighty":-1.425394,"marketCap":23097313},{"date":"2022-11-11","current":-1.408127,"twenty":-3.189974,"median":-2.07759,"eighty":-1.412118,"marketCap":23578262},{"date":"2022-11-18","current":-1.443023,"twenty":-3.189974,"median":-2.064822,"eighty":-1.412118,"marketCap":23489962},{"date":"2022-11-25","current":-1.40839,"twenty":-3.187227,"median":-2.05313,"eighty":-1.408023,"marketCap":22926202},{"date":"2022-12-02","current":-1.41777,"twenty":-3.187227,"median":-2.033221,"eighty":-1.407788,"marketCap":23078887},{"date":"2022-12-09","current":-1.352841,"twenty":-3.187227,"median":-2.031812,"eighty":-1.404494,"marketCap":22021956},{"date":"2022-12-16","current":-1.217911,"twenty":-3.187227,"median":-2.018289,"eighty":-1.401479,"marketCap":19825527},{"date":"2022-12-23","current":-1.047529,"twenty":-3.187227,"median":-2.018289,"eighty":-1.392728,"marketCap":17051998},{"date":"2022-12-30","current":-0.759278,"twenty":-3.187227,"median":-2.018289,"eighty":-1.390017,"marketCap":12359758},{"date":"2023-01-06","current":-1.004183,"twenty":-3.187227,"median":-2.018289,"eighty":-1.383663,"marketCap":16346398},{"date":"2023-01-13","current":-0.962622,"twenty":-3.187227,"median":-2.018289,"eighty":-1.383663,"marketCap":15669857},{"date":"2023-01-20","current":-0.977497,"twenty":-3.187227,"median":-2.018289,"eighty":-1.383663,"marketCap":15911996},{"date":"2023-01-27","current":-0.74691,"twenty":-3.187227,"median":-2.018289,"eighty":-1.381744,"marketCap":12158429},{"date":"2023-02-03","current":-0.85985,"twenty":-3.187227,"median":-2.018289,"eighty":-1.376384,"marketCap":13996901},{"date":"2023-02-10","current":-0.772209,"twenty":-3.187227,"median":-2.018289,"eighty":-1.374309,"marketCap":12570247},{"date":"2023-02-17","current":-0.678242,"twenty":-3.187227,"median":-2.018289,"eighty":-1.3728,"marketCap":11040638},{"date":"2023-02-24","current":-0.592589,"twenty":-3.187227,"median":-2.018289,"eighty":-1.3728,"marketCap":9646341},{"date":"2023-03-03","current":-0.532475,"twenty":-3.187227,"median":-2.018289,"eighty":-1.3728,"marketCap":8667783},{"date":"2023-03-10","current":-0.434882,"twenty":-3.187227,"median":-2.016215,"eighty":-1.368534,"marketCap":7079147},{"date":"2023-03-17","current":-0.361408,"twenty":-3.187227,"median":-2.016215,"eighty":-1.360252,"marketCap":5883111},{"date":"2023-03-24","current":-0.328881,"twenty":-3.187227,"median":-2.016215,"eighty":-1.351048,"marketCap":5353631},{"date":"2023-03-31","current":-0.39626,"twenty":-3.186947,"median":-2.016008,"eighty":-1.349068,"marketCap":6450439},{"date":"2023-04-06","current":-0.41321,"twenty":-3.187227,"median":-2.016215,"eighty":-1.34901,"marketCap":6726356},{"date":"2023-04-14","current":-0.387911,"twenty":-3.187507,"median":-2.017252,"eighty":-1.347501,"marketCap":6314539},{"date":"2023-04-21","current":-0.454855,"twenty":-3.187507,"median":-2.017252,"eighty":-1.344781,"marketCap":6499148},{"date":"2023-04-27","current":-0.396758,"twenty":-3.187787,"median":-2.018289,"eighty":-1.344202,"marketCap":5669039},{"date":"2023-05-05","current":-0.375504,"twenty":-3.188067,"median":-2.019368,"eighty":-1.346518,"marketCap":5365341},{"date":"2023-05-12","current":-0.453835,"twenty":-3.188067,"median":-2.019368,"eighty":-1.343623,"marketCap":6484571},{"date":"2023-05-19","current":-0.482667,"twenty":-3.188067,"median":-2.019368,"eighty":-1.343623,"marketCap":6053724},{"date":"2023-05-26","current":-0.485896,"twenty":-3.188067,"median":-2.019368,"eighty":-1.343623,"marketCap":6094217},{"date":"2023-06-02","current":-0.465717,"twenty":-3.188067,"median":-2.019368,"eighty":-1.342184,"marketCap":5841135},{"date":"2023-06-09","current":-0.487526,"twenty":-3.188067,"median":-2.019368,"eighty":-1.338064,"marketCap":6114666},{"date":"2023-06-16","current":-0.484281,"twenty":-3.188067,"median":-2.019368,"eighty":-1.337963,"marketCap":6073971},{"date":"2023-06-23","current":-0.499068,"twenty":-3.188448,"median":-2.020446,"eighty":-1.335617,"marketCap":6259429},{"date":"2023-06-30","current":-0.54401,"twenty":-3.18883,"median":-2.020938,"eighty":-1.332931,"marketCap":6823094},{"date":"2023-07-07","current":-0.534324,"twenty":-3.18883,"median":-2.020938,"eighty":-1.332931,"marketCap":6701614},{"date":"2023-07-14","current":-0.587595,"twenty":-3.18883,"median":-2.020938,"eighty":-1.332931,"marketCap":7369751},{"date":"2023-07-21","current":-0.639251,"twenty":-3.18883,"median":-2.020938,"eighty":-1.332931,"marketCap":8017641},{"date":"2023-07-28","current":-0.637621,"twenty":-3.18883,"median":-2.020938,"eighty":-1.332931,"marketCap":7997192},{"date":"2023-08-04","current":-0.615037,"twenty":-3.18883,"median":-2.020938,"eighty":-1.332931,"marketCap":7713943},{"date":"2023-08-11","current":-0.741167,"twenty":-3.18883,"median":-2.020938,"eighty":-1.332931,"marketCap":9295890},{"date":"2023-08-18","current":-0.645251,"twenty":-3.18883,"median":-2.020938,"eighty":-1.332931,"marketCap":7745124},{"date":"2023-08-25","current":-0.636788,"twenty":-3.18883,"median":-2.020938,"eighty":-1.332931,"marketCap":7643548},{"date":"2023-09-01","current":-0.761608,"twenty":-3.18883,"median":-2.020938,"eighty":-1.332931,"marketCap":9141786},{"date":"2023-09-08","current":-0.687562,"twenty":-3.18883,"median":-2.020938,"eighty":-1.332931,"marketCap":8253001},{"date":"2023-09-15","current":-0.636788,"twenty":-3.18883,"median":-2.020938,"eighty":-1.332931,"marketCap":7643548},{"date":"2023-09-22","current":-0.638904,"twenty":-3.18883,"median":-2.020938,"eighty":-1.332931,"marketCap":7668942},{"date":"2023-09-29","current":-0.621979,"twenty":-3.18883,"median":-2.020938,"eighty":-1.324098,"marketCap":7465791},{"date":"2023-10-06","current":-0.772185,"twenty":-3.174339,"median":-2.013032,"eighty":-1.314157,"marketCap":9268755},{"date":"2023-10-13","current":-0.733047,"twenty":-3.166757,"median":-2.00486,"eighty":-1.305907,"marketCap":8798969},{"date":"2023-10-20","current":-0.71718,"twenty":-3.151021,"median":-1.998276,"eighty":-1.298932,"marketCap":8608515},{"date":"2023-10-27","current":-0.734105,"twenty":-3.141626,"median":-1.994232,"eighty":-1.294949,"marketCap":8811665},{"date":"2023-11-03","current":-0.820844,"twenty":-3.127922,"median":-1.989255,"eighty":-1.267635,"marketCap":9852813},{"date":"2023-11-10","current":-0.793341,"twenty":-3.113116,"median":-1.9793,"eighty":-1.252535,"marketCap":9522693},{"date":"2023-11-17","current":-0.931923,"twenty":-3.107478,"median":-1.968516,"eighty":-1.220923,"marketCap":9455336},{"date":"2023-11-24","current":-0.911664,"twenty":-3.107478,"median":-1.960636,"eighty":-1.208664,"marketCap":9249786},{"date":"2023-12-01","current":-0.906599,"twenty":-3.106947,"median":-1.949437,"eighty":-1.189465,"marketCap":9198398},{"date":"2023-12-08","current":-1.142138,"twenty":-3.091166,"median":-1.941802,"eighty":-1.171272,"marketCap":11588183},{"date":"2023-12-15","current":-1.375093,"twenty":-3.083962,"median":-1.927094,"eighty":-1.171272,"marketCap":13951760},{"date":"2023-12-22","current":-1.364938,"twenty":-3.0826,"median":-1.912999,"eighty":-1.171272,"marketCap":13848728},{"date":"2023-12-29","current":-1.359899,"twenty":-3.082913,"median":-1.906488,"eighty":-1.171106,"marketCap":13797597},{"date":"2024-01-05","current":-1.533545,"twenty":-3.083175,"median":-1.894516,"eighty":-1.170818,"marketCap":15559424},{"date":"2024-01-12","current":-1.487785,"twenty":-3.074933,"median":-1.886137,"eighty":-1.170818,"marketCap":15095136},{"date":"2024-01-19","current":-1.533356,"twenty":-3.067186,"median":-1.879045,"eighty":-1.170531,"marketCap":15557499},{"date":"2024-01-26","current":-1.442265,"twenty":-3.058879,"median":-1.866113,"eighty":-1.170818,"marketCap":14633291},{"date":"2024-02-02","current":-0.695324,"twenty":-3.039181,"median":-1.860995,"eighty":-1.160947,"marketCap":7054786},{"date":"2024-02-09","current":-1.178103,"twenty":-3.035903,"median":-1.844905,"eighty":-1.151275,"marketCap":11953088},{"date":"2024-02-16","current":-1.093085,"twenty":-3.022501,"median":-1.825867,"eighty":-1.141436,"marketCap":11090494},{"date":"2024-02-23","current":-0.998958,"twenty":-3.005803,"median":-1.80799,"eighty":-1.118738,"marketCap":10135479},{"date":"2024-03-01","current":-0.631516,"twenty":-2.996391,"median":-1.797615,"eighty":-1.071799,"marketCap":6407390},{"date":"2024-03-08","current":-0.653641,"twenty":-2.980659,"median":-1.783527,"eighty":-1.018695,"marketCap":6631873},{"date":"2024-03-15","current":-0.635932,"twenty":-2.971483,"median":-1.776064,"eighty":-0.998958,"marketCap":6452197},{"date":"2024-03-22","current":-0.649181,"twenty":-2.94788,"median":-1.764569,"eighty":-0.959486,"marketCap":6586618},{"date":"2024-03-28","current":-0.618267,"twenty":-2.917031,"median":-1.755168,"eighty":-0.936988,"marketCap":6272970},{"date":"2024-04-05","current":-0.255968,"twenty":-2.912853,"median":-1.747055,"eighty":-0.917735,"marketCap":5287217},{"date":"2024-04-12","current":-0.266815,"twenty":-2.912853,"median":-1.738417,"eighty":-0.910145,"marketCap":5511252},{"date":"2024-04-19","current":-0.245122,"twenty":-2.912853,"median":-1.718492,"eighty":-0.900701,"marketCap":5063183},{"date":"2024-04-26","current":-0.229938,"twenty":-2.911808,"median":-1.715073,"eighty":-0.886365,"marketCap":4749534},{"date":"2024-05-03","current":-0.22779,"twenty":-2.911808,"median":-1.710951,"eighty":-0.85985,"marketCap":4705175},{"date":"2024-05-10","current":-0.299353,"twenty":-2.911808,"median":-1.700572,"eighty":-0.820844,"marketCap":6183356},{"date":"2024-05-17","current":-0.362671,"twenty":-2.911808,"median":-1.690638,"eighty":-0.802326,"marketCap":7348336},{"date":"2024-05-24","current":-0.482087,"twenty":-2.911808,"median":-1.688174,"eighty":-0.793341,"marketCap":9767910},{"date":"2024-05-31","current":-0.451127,"twenty":-2.911808,"median":-1.667608,"eighty":-0.773004,"marketCap":9140613},{"date":"2024-06-07","current":-0.380362,"twenty":-2.911808,"median":-1.657178,"eighty":-0.763776,"marketCap":7706791},{"date":"2024-06-14","current":-0.373728,"twenty":-2.912853,"median":-1.647066,"eighty":-0.752129,"marketCap":7572371},{"date":"2024-06-21","current":-0.320654,"twenty":-2.913897,"median":-1.635191,"eighty":-0.743905,"marketCap":6497004},{"date":"2024-06-28","current":-0.218929,"twenty":-2.917031,"median":-1.631335,"eighty":-0.734105,"marketCap":4435886},{"date":"2024-07-05","current":-0.283693,"twenty":-2.917031,"median":-1.62694,"eighty":-0.73199,"marketCap":5748113},{"date":"2024-07-12","current":-0.31399,"twenty":-2.917031,"median":-1.622782,"eighty":-0.723527,"marketCap":6361990},{"date":"2024-07-15","current":-0.307105,"twenty":-2.917031,"median":-1.618262,"eighty":-0.719296,"marketCap":6222472},{"date":"2024-08-02","current":-0.278184,"twenty":-2.933031,"median":-1.608319,"eighty":-0.712949,"marketCap":5636499},{"date":"2024-08-09","current":-0.297465,"twenty":-2.933031,"median":-1.601986,"eighty":-0.692639,"marketCap":6027148},{"date":"2024-08-16","current":-0.41177,"twenty":-2.933031,"median":-1.599817,"eighty":-0.680124,"marketCap":8036197},{"date":"2024-08-23","current":-0.257756,"twenty":-2.933031,"median":-1.599817,"eighty":-0.675715,"marketCap":5030436},{"date":"2024-08-30","current":-0.328844,"twenty":-2.933031,"median":-1.599817,"eighty":-0.666049,"marketCap":6417796},{"date":"2024-09-06","current":-0.368197,"twenty":-2.933031,"median":-1.599817,"eighty":-0.653111,"marketCap":7185820},{"date":"2024-09-13","current":-0.221843,"twenty":-2.933031,"median":-1.59879,"eighty":-0.646226,"marketCap":4329535},{"date":"2024-09-20","current":-0.212969,"twenty":-2.933031,"median":-1.588721,"eighty":-0.643787,"marketCap":4156354},{"date":"2024-09-27","current":-0.178362,"twenty":-2.933031,"median":-1.581602,"eighty":-0.638164,"marketCap":3480946},{"date":"2024-10-04","current":-0.177385,"twenty":-2.933031,"median":-1.577936,"eighty":-0.636788,"marketCap":3461896},{"date":"2024-10-11","current":-0.171706,"twenty":-2.933031,"median":-1.577936,"eighty":-0.634673,"marketCap":3351060},{"date":"2024-10-18","current":-0.144153,"twenty":-2.933031,"median":-1.577936,"eighty":-0.631506,"marketCap":2813332},{"date":"2024-10-25","current":-0.141935,"twenty":-2.933031,"median":-1.577108,"eighty":-0.62759,"marketCap":2770036},{"date":"2024-10-31","current":-0.172483,"twenty":-2.933031,"median":-1.577108,"eighty":-0.622684,"marketCap":3366211},{"date":"2024-11-08","current":-0.184498,"twenty":-2.935477,"median":-1.573646,"eighty":-0.619342,"marketCap":3600707},{"date":"2024-11-15","current":-0.185414,"twenty":-2.935477,"median":-1.568553,"eighty":-0.614088,"marketCap":3702008},{"date":"2024-11-22","current":-0.165517,"twenty":-2.935477,"median":-1.562062,"eighty":-0.602681,"marketCap":3304751},{"date":"2024-11-29","current":-0.19451,"twenty":-2.935477,"median":-1.55437,"eighty":-0.592967,"marketCap":3883632},{"date":"2024-12-06","current":-0.220078,"twenty":-2.935477,"median":-1.546406,"eighty":-0.587595,"marketCap":4394122},{"date":"2024-12-13","current":-0.199281,"twenty":-2.935477,"median":-1.534779,"eighty":-0.560905,"marketCap":3978891},{"date":"2024-12-20","current":-0.229987,"twenty":-2.935477,"median":-1.519845,"eighty":-0.548206,"marketCap":4591967},{"date":"2024-12-27","current":-0.239773,"twenty":-2.935477,"median":-1.510443,"eighty":-0.54401,"marketCap":4787370},{"date":"2025-01-03","current":-0.220139,"twenty":-2.935477,"median":-1.500714,"eighty":-0.532522,"marketCap":4395343},{"date":"2025-01-10","current":-0.204052,"twenty":-2.937923,"median":-1.501473,"eighty":-0.514712,"marketCap":4074150},{"date":"2025-01-17","current":-0.182277,"twenty":-2.937923,"median":-1.501473,"eighty":-0.499068,"marketCap":3639378},{"date":"2025-01-24","current":-0.173713,"twenty":-2.937923,"median":-1.501473,"eighty":-0.495565,"marketCap":3468401},{"date":"2025-01-31","current":-0.187537,"twenty":-2.937923,"median":-1.501473,"eighty":-0.490739,"marketCap":3744407},{"date":"2025-02-07","current":-0.195695,"twenty":-2.937923,"median":-1.499956,"eighty":-0.485896,"marketCap":3907294},{"date":"2025-02-14","current":-0.201875,"twenty":-2.937923,"median":-1.486869,"eighty":-0.482667,"marketCap":4030682},{"date":"2025-02-21","current":-0.194185,"twenty":-2.937923,"median":-1.479098,"eighty":-0.481053,"marketCap":3877132},{"date":"2025-02-28","current":-0.186769,"twenty":-2.937923,"median":-1.466529,"eighty":-0.469521,"marketCap":3729066},{"date":"2025-03-07","current":-0.190408,"twenty":-2.939914,"median":-1.457447,"eighty":-0.457122,"marketCap":3801728},{"date":"2025-03-14","current":-0.197206,"twenty":-2.939914,"median":-1.445515,"eighty":-0.448617,"marketCap":3937455},{"date":"2025-03-21","current":-0.519613,"twenty":-2.939914,"median":-1.431626,"eighty":-0.446574,"marketCap":5491231},{"date":"2025-03-28","current":-0.475516,"twenty":-2.939914,"median":-1.418852,"eighty":-0.446574,"marketCap":5025217},{"date":"2025-04-04","current":-0.420243,"twenty":-2.939914,"median":-1.40839,"eighty":-0.434372,"marketCap":4441089},{"date":"2025-04-11","current":-0.359685,"twenty":-2.937923,"median":-1.407668,"eighty":-0.428995,"marketCap":3801126},{"date":"2025-04-17","current":-0.362937,"twenty":-2.937923,"median":-1.404782,"eighty":-0.420243,"marketCap":3835486},{"date":"2025-04-25","current":-0.394435,"twenty":-2.939914,"median":-1.405103,"eighty":-0.41018,"marketCap":4168353},{"date":"2025-05-02","current":-0.400328,"twenty":-2.939914,"median":-1.404421,"eighty":-0.400328,"marketCap":4230631},{"date":"2025-05-09","current":-0.365782,"twenty":-2.939914,"median":-1.391698,"eighty":-0.396758,"marketCap":3865552},{"date":"2025-05-16","current":-0.404399,"twenty":-2.939914,"median":-1.374937,"eighty":-0.39622,"marketCap":4179091},{"date":"2025-05-23","current":-0.403776,"twenty":-2.939914,"median":-1.36773,"eighty":-0.39622,"marketCap":4172648},{"date":"2025-05-30","current":-0.275141,"twenty":-2.939914,"median":-1.36146,"eighty":-0.394394,"marketCap":2843328},{"date":"2025-06-06","current":-0.244499,"twenty":-2.939914,"median":-1.352222,"eighty":-0.38911,"marketCap":2526671},{"date":"2025-06-13","current":-0.320688,"twenty":-2.939914,"median":-1.344351,"eighty":-0.380403,"marketCap":3314019},{"date":"2025-06-20","current":-0.256966,"twenty":-2.941906,"median":-1.336239,"eighty":-0.378225,"marketCap":2655510},{"date":"2025-06-27","current":-0.241728,"twenty":-2.941906,"median":-1.315232,"eighty":-0.374195,"marketCap":2498040},{"date":"2025-07-03","current":-0.121837,"twenty":-2.941906,"median":-1.305199,"eighty":-0.370937,"marketCap":1259078},{"date":"2025-07-11","current":-0.116263,"twenty":-2.923787,"median":-1.288991,"eighty":-0.363913,"marketCap":1201473},{"date":"2025-07-18","current":-0.113874,"twenty":-2.908414,"median":-1.262203,"eighty":-0.362671,"marketCap":1176785},{"date":"2025-07-25","current":-0.113874,"twenty":-2.890554,"median":-1.243408,"eighty":-0.35911,"marketCap":1176785},{"date":"2025-08-01","current":-0.100337,"twenty":-2.884086,"median":-1.21673,"eighty":-0.353944,"marketCap":1036888},{"date":"2025-08-08","current":-0.103522,"twenty":-2.842429,"median":-1.189465,"eighty":-0.347423,"marketCap":1069805},{"date":"2025-08-15","current":-0.476781,"twenty":-2.827104,"median":-1.171106,"eighty":-0.345461,"marketCap":4911335},{"date":"2025-08-22","current":-0.432709,"twenty":-2.827104,"median":-1.153425,"eighty":-0.345461,"marketCap":4457346},{"date":"2025-08-29","current":-0.448094,"twenty":-2.827104,"median":-1.12871,"eighty":-0.345461,"marketCap":4615830},{"date":"2025-09-05","current":-0.424696,"twenty":-2.830075,"median":-1.102981,"eighty":-0.345461,"marketCap":4374803},{"date":"2025-09-12","current":-0.460755,"twenty":-2.827104,"median":-1.053643,"eighty":-0.345461,"marketCap":4746248},{"date":"2025-09-19","current":-0.484794,"twenty":-2.827104,"median":-1.008067,"eighty":-0.345461,"marketCap":4993879},{"date":"2025-09-26","current":-0.51284,"twenty":-2.827104,"median":-0.98251,"eighty":-0.345461,"marketCap":5282781},{"date":"2025-10-03","current":-0.540886,"twenty":-2.827104,"median":-0.948556,"eighty":-0.345461,"marketCap":5571683},{"date":"2025-10-10","current":-0.556913,"twenty":-2.827104,"median":-0.924301,"eighty":-0.345461,"marketCap":5736770},{"date":"2025-10-17","current":-0.520854,"twenty":-2.827104,"median":-0.911664,"eighty":-0.345461,"marketCap":5365324},{"date":"2025-10-24","current":-0.51284,"twenty":-2.827104,"median":-0.903765,"eighty":-0.345461,"marketCap":5282781},{"date":"2025-10-31","current":-0.492808,"twenty":-2.827104,"median":-0.896115,"eighty":-0.345461,"marketCap":5076422},{"date":"2025-11-07","current":-0.446732,"twenty":-2.827104,"median":-0.863765,"eighty":-0.345461,"marketCap":4601797},{"date":"2025-11-14","current":-0.435753,"twenty":-2.827104,"median":-0.842358,"eighty":-0.345461,"marketCap":4751774},{"date":"2025-11-21","current":-0.348946,"twenty":-2.827104,"median":-0.803919,"eighty":-0.345461,"marketCap":3805170},{"date":"2025-11-28","current":-0.332548,"twenty":-2.827104,"median":-0.801804,"eighty":-0.341918,"marketCap":3626354},{"date":"2025-12-05","current":-0.325515,"twenty":-2.827104,"median":-0.775823,"eighty":-0.333239,"marketCap":3549658},{"date":"2025-12-12","current":-0.35575,"twenty":-2.827104,"median":-0.772185,"eighty":-0.333239,"marketCap":3879365},{"date":"2025-12-19","current":-0.315309,"twenty":-2.827104,"median":-0.755343,"eighty":-0.328866,"marketCap":3438367},{"date":"2025-12-26","current":-0.319208,"twenty":-2.827104,"median":-0.74546,"eighty":-0.325463,"marketCap":3480883},{"date":"2026-01-02","current":-0.29937,"twenty":-2.827104,"median":-0.734105,"eighty":-0.322307,"marketCap":3264552},{"date":"2026-01-09","current":-0.324904,"twenty":-2.819548,"median":-0.73199,"eighty":-0.320924,"marketCap":3542989},{"date":"2026-01-16","current":-0.358235,"twenty":-2.81035,"median":-0.719296,"eighty":-0.320674,"marketCap":3906458},{"date":"2026-01-23","current":-0.354489,"twenty":-2.795672,"median":-0.712949,"eighty":-0.320674,"marketCap":3865610},{"date":"2026-01-30","current":-0.321197,"twenty":-2.767001,"median":-0.691793,"eighty":-0.319369,"marketCap":3502571},{"date":"2026-02-06","current":-0.254118,"twenty":-2.744156,"median":-0.6791,"eighty":-0.319052,"marketCap":2771091},{"date":"2026-02-13","current":-0.25228,"twenty":-2.728907,"median":-0.674869,"eighty":-0.315502,"marketCap":2751045},{"date":"2026-02-20","current":-0.269959,"twenty":-2.714712,"median":-0.669923,"eighty":-0.313345,"marketCap":2943832},{"date":"2026-02-27","current":-0.344117,"twenty":-2.689881,"median":-0.652757,"eighty":-0.309543,"marketCap":3752511},{"date":"2026-03-06","current":-0.34752,"twenty":-2.669332,"median":-0.645466,"eighty":-0.309543,"marketCap":3789618},{"date":"2026-03-13","current":-0.37533,"twenty":-2.645408,"median":-0.643135,"eighty":-0.309543,"marketCap":4092873},{"date":"2026-03-20","current":-0.331376,"twenty":-2.634063,"median":-0.637671,"eighty":-0.309543,"marketCap":3261561},{"date":"2026-03-27","current":-0.254721,"twenty":-2.622246,"median":-0.636788,"eighty":-0.30665,"marketCap":2507091},{"date":"2026-04-02","current":-0.242298,"twenty":-2.602928,"median":-0.634673,"eighty":-0.302403,"marketCap":2384815},{"date":"2026-04-10","current":-0.273136,"twenty":-2.586203,"median":-0.631516,"eighty":-0.299333,"marketCap":2688337},{"date":"2026-04-17","current":-0.299613,"twenty":-2.554792,"median":-0.628326,"eighty":-0.297057,"marketCap":2948933},{"date":"2026-04-24","current":-0.277982,"twenty":-2.531951,"median":-0.622684,"eighty":-0.293131,"marketCap":2736034},{"date":"2026-05-01","current":-0.26177,"twenty":-2.508179,"median":-0.619212,"eighty":-0.291305,"marketCap":2576468},{"date":"2026-05-08","current":-0.270052,"twenty":-2.489139,"median":-0.613851,"eighty":-0.28831,"marketCap":2657985},{"date":"2026-05-15","current":-0.25182,"twenty":-2.453151,"median":-0.600803,"eighty":-0.285262,"marketCap":2474571},{"date":"2026-05-22","current":-0.260336,"twenty":-2.432963,"median":-0.592438,"eighty":-0.28133,"marketCap":2558257},{"date":"2026-05-29","current":-0.275537,"twenty":-2.415626,"median":-0.587595,"eighty":-0.278834,"marketCap":2707625},{"date":"2026-06-05","current":-0.27595,"twenty":-2.400242,"median":-0.563797,"eighty":-0.277904,"marketCap":2711686},{"date":"2026-06-12","current":-0.285592,"twenty":-2.375521,"median":-0.555277,"eighty":-0.276827,"marketCap":2806437},{"date":"2026-06-18","current":-0.280082,"twenty":-2.359156,"median":-0.5489,"eighty":-0.276827,"marketCap":2752293},{"date":"2026-06-26","current":-0.262864,"twenty":-2.335209,"median":-0.544451,"eighty":-0.275281,"marketCap":2583095},{"date":"2026-07-02","current":-0.278291,"twenty":-2.324084,"median":-0.540886,"eighty":-0.273527,"marketCap":2734697},{"date":"2026-07-10","current":-0.264655,"twenty":-2.290496,"median":-0.532792,"eighty":-0.272093,"marketCap":2600692},{"date":"2026-07-17","current":-0.256114,"twenty":-2.267943,"median":-0.528351,"eighty":-0.270624,"marketCap":2516769},{"date":"2026-07-24","current":-0.231917,"twenty":-2.247151,"median":-0.52486,"eighty":-0.269716,"marketCap":2278989},{"date":"2026-07-31","current":-0.225076,"twenty":-2.220022,"median":-0.520854,"eighty":-0.269145,"marketCap":2211761},{"date":"2026-08-07","current":-0.249571,"twenty":-2.169072,"median":-0.516847,"eighty":-0.266363,"marketCap":2452469},{"date":"2026-08-14","current":-0.243396,"twenty":-2.112803,"median":-0.51284,"eighty":-0.265441,"marketCap":2391788},{"date":"2026-08-21","current":-0.24163,"twenty":-2.07759,"median":-0.508834,"eighty":-0.263956,"marketCap":2436456},{"date":"2026-08-28","current":-0.238051,"twenty":-2.008683,"median":-0.500424,"eighty":-0.262526,"marketCap":2400361},{"date":"2026-09-02","current":-0.223284,"twenty":-1.980415,"median":-0.49881,"eighty":-0.260612,"marketCap":2251466}],"updateTime":1788475623509},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OGEN\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2633142134","title":"Oragenics Inc - to Issue 3.25 Mln Restricted Preferred Shares to Sigyn, Convertible One-to-One","url":"https://stock-news.laohu8.com/highlight/detail?id=2633142134","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633142134?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:30","pubTimestamp":1778157040,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nFWN41K0Y8:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OGEN","BK4139","SIGY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633142836","title":"BRIEF-Oragenics Inc - Signs Letter Of Intent To License Cardiodialysis From Sigyn Therapeutics - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2633142836","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633142836?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:19","pubTimestamp":1778156356,"startTime":"0","endTime":"0","summary":"BRIEF-Oragenics Inc - Signs Letter Of Intent To License Cardiodialysis From Sigyn Therapeutics - SEC FilingMay 7  - Oragenics Inc OGEN.A:ORAGENICS INC - SIGNS LETTER OF INTENT TO LICENSE CARDIODIALYSIS FROM SIGYN THERAPEUTICS - SEC FILINGORAGENICS INC - TO RECEIVE EXCLUSIVE LICENSE FOR CARDIODIALYSIS FOR TBI AND NEURODEGENERATIVE DISEASES - SEC FILINGSource text: []Further company coverage: OGEN.A ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nFWN41K1BI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633706144","title":"Oragenics Inc - Signs Letter of Intent to License Cardiodialysis From Sigyn Therapeutics - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2633706144","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633706144?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:18","pubTimestamp":1778156319,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nFWN41K1BI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","OGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633144704","title":"Oragenics Inc - to Receive Exclusive License for Cardiodialysis for Tbi and Neurodegenerative Diseases - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2633144704","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633144704?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:18","pubTimestamp":1778156319,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nFWN41K1BI:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633144716","title":"Oragenics signs LOI to license Sigyn CardioDialysis technology for TBI treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2633144716","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633144716?lang=en_us&edition=fundamental","pubTime":"2026-05-07 20:16","pubTimestamp":1778156179,"startTime":"0","endTime":"0","summary":"Oragenics signed non-binding letter of intent to license Sigyn Therapeutics’ CardioDialysis blood purification technology for traumatic brain injury, expanding its concussion and mild TBI program.Proposed deal grants exclusive, assignable rights to develop and commercialize CardioDialysis for TBI and other chronic neurodegenerative diseases.Consideration includes issuance of 3,250,000 shares of new restricted preferred stock, convertible one-for-one into common stock, subject to NYSE American rules and shareholder approval.Sigyn would receive 3% royalty on revenue for six years following FDA market clearance, measured from first commercial sale per indication and country.Target closing set for within 90 days, subject to due diligence, board approvals, independent valuation, and other customary conditions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDLc01Qyk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OGEN","BK4139","SIGY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633394354","title":"Oragenics Activates Second Site In Phase Iia Clinical Trial Of Onp-002 For Concussion And Mild Traumatic Brain Injury.","url":"https://stock-news.laohu8.com/highlight/detail?id=2633394354","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633394354?lang=en_us&edition=fundamental","pubTime":"2026-05-05 20:48","pubTimestamp":1777985290,"startTime":"0","endTime":"0","summary":"May 5 (Reuters) - Oragenics Inc ::*ORAGENICS ACTIVATES SECOND SITE IN PHASE IIA CLINICAL TRIAL OF ONP-002 FOR CONCUSSION AND MILD TRAUMATIC BRAIN INJURY.*ORAGENICS INC: PHASE IIA CLINICAL DATA READOUT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nRSDbVLhSG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633948124","title":"Oragenics activates second site for Phase IIa ONP-002 concussion trial in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2633948124","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633948124?lang=en_us&edition=fundamental","pubTime":"2026-05-05 20:32","pubTimestamp":1777984361,"startTime":"0","endTime":"0","summary":"Oragenics activated a second site in its Phase IIa trial of ONP-002 for concussion and mild traumatic brain injury, with Alfred Hospital now enrolling alongside Mackay Base Hospital in Queensland.Four patients have been enrolled and dosed so far at Mackay Base Hospital.Trial targets 40 patients, with dosing starting within 12 hours of injury and continuing for up to 30 days, aiming to test whether ONP-002 can address underlying injury biology rather than only symptoms.Results have not been presented; Phase IIa data are expected before year-end 2026.Readout is expected to support an FDA IND submission targeted for Dec. 31, 2026, ahead of a planned Phase IIb trial in the U.S.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oragenics Inc. ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDL6B2tWR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633948191","title":"Oragenics Inc: Phase Iia Clinical Data Readout Is Projected Before Year-End 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2633948191","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633948191?lang=en_us&edition=fundamental","pubTime":"2026-05-05 20:31","pubTimestamp":1777984261,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nFWN41I0XX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","OGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628729559","title":"Oragenics announces 8 drug doses administered in Phase IIa trial of ONP-002","url":"https://stock-news.laohu8.com/highlight/detail?id=2628729559","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628729559?lang=en_us&edition=fundamental","pubTime":"2026-04-20 22:01","pubTimestamp":1776693673,"startTime":"0","endTime":"0","summary":"Oragenics (OGEN) announced that 2 patients and 8 study drug doses have been administered in its ongoing Phase IIa clinical trial evaluating ONP-002...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/oragenics-announces-8-drug-doses-administered-in-phase-iia-trial-of-onp-002-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/oragenics-announces-8-drug-doses-administered-in-phase-iia-trial-of-onp-002-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628513725","title":"Oragenics doses 2 patients in Phase IIa ONP-002 concussion trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2628513725","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628513725?lang=en_us&edition=fundamental","pubTime":"2026-04-20 21:03","pubTimestamp":1776690189,"startTime":"0","endTime":"0","summary":"Oragenics reported early dosing progress in ongoing Phase IIa trial of ONP-002 for mild traumatic brain injury, with 2 patients treated and 8 doses administered.Results have not been presented; trial is continuing to enroll patients, with dosing starting within 12 hours of concussion and treatment continuing for up to 30 days.Update signals trial execution momentum for ONP-002, positioned as a potential first pharmacological option aimed at treating underlying concussion injury rather than symptom management.Company targets enrollment of 40 patients, with recruitment underway at Mackay Base Hospital in Queensland, Australia.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oragenics Inc. published the original content used to generate th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL1hXP7R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628230987","title":"Oragenics Reports 8 Study Drug Doses in Phase Iia Clinical Trial of Onp-002 for Mild Traumatic Brain Injury","url":"https://stock-news.laohu8.com/highlight/detail?id=2628230987","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628230987?lang=en_us&edition=fundamental","pubTime":"2026-04-20 21:00","pubTimestamp":1776690050,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nFWN4130VB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627458029","title":"Oragenics doses first patient in Phase IIa ONP-002 concussion trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2627458029","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627458029?lang=en_us&edition=fundamental","pubTime":"2026-04-13 20:32","pubTimestamp":1776083526,"startTime":"0","endTime":"0","summary":"Oragenics dosed first patient in Phase IIa trial of ONP-002 for concussion and mild traumatic brain injury, marking start of patient testing rather than results reporting.Study will generate future safety, tolerability, and feasibility findings; no clinical outcomes have been presented yet.Randomized, placebo-controlled trial targets 40 patients, with initial dosing within 12 hours of injury followed by up to 30 days of treatment.Oragenics plans to use Phase IIa findings to support FDA IND submission targeted for Q4 2026 for next-stage US trials.Program builds on Phase 1 experience that reported no serious adverse events, supporting continued development of intranasal ONP-002 as potential pharmacological option for concussion.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as f","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nNDL1q6WCR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624554444","title":"Oragenics Sets New 2025 Annual Shareholder Meeting Date","url":"https://stock-news.laohu8.com/highlight/detail?id=2624554444","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624554444?lang=en_us&edition=fundamental","pubTime":"2026-04-01 07:45","pubTimestamp":1775000726,"startTime":"0","endTime":"0","summary":"The latest update is out from Oragenics ( ($OGEN) ). On March 27, 2026, Oragenics’ board set June 29, 2026 as the date for the company’s 2025 annua...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/oragenics-sets-new-2025-annual-shareholder-meeting-date?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/oragenics-sets-new-2025-annual-shareholder-meeting-date?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624379785","title":"Oragenics changes annual shareholder meeting date to late June 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2624379785","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624379785?lang=en_us&edition=fundamental","pubTime":"2026-04-01 04:08","pubTimestamp":1774987693,"startTime":"0","endTime":"0","summary":"Oragenics set 2025 annual shareholder meeting for June 29, 2026.Meeting date shifted by more than 30 days versus anniversary of 2024 annual meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oragenics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 31, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDLbs0c6m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622888606","title":"Oragenics receives audit opinion with going concern explanation","url":"https://stock-news.laohu8.com/highlight/detail?id=2622888606","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622888606?lang=en_us&edition=fundamental","pubTime":"2026-03-26 06:35","pubTimestamp":1774478116,"startTime":"0","endTime":"0","summary":"Oragenics (OGEN)announced that, as previously disclosed in its 2025 Annual Report filed on March 16, the audited consolidated financial statements ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/oragenics-receives-audit-opinion-with-going-concern-explanation-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/oragenics-receives-audit-opinion-with-going-concern-explanation-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622161888","title":"Oragenics, Inc. Receives Audit Opinion with Going Concern Explanation","url":"https://stock-news.laohu8.com/highlight/detail?id=2622161888","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622161888?lang=en_us&edition=fundamental","pubTime":"2026-03-26 06:30","pubTimestamp":1774477800,"startTime":"0","endTime":"0","summary":"SARASOTA, Fla., March  25, 2026 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company pioneering brain-targeted therapeutics through proprietary intranasal ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/25/3262664/0/en/Oragenics-Inc-Receives-Audit-Opinion-with-Going-Concern-Explanation.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620340427","title":"Oragenics files annual report on Form 10-K","url":"https://stock-news.laohu8.com/highlight/detail?id=2620340427","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620340427?lang=en_us&edition=fundamental","pubTime":"2026-03-17 20:49","pubTimestamp":1773751782,"startTime":"0","endTime":"0","summary":"Oragenics (OGEN) announced the filing of its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, with the U.S. Securities and E...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/oragenics-files-annual-report-on-form-10-k-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/oragenics-files-annual-report-on-form-10-k-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","OGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620919204","title":"Oragenics FY 2025 net loss narrows 6.86% to USD 9.84 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2620919204","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620919204?lang=en_us&edition=fundamental","pubTime":"2026-03-17 04:34","pubTimestamp":1773693274,"startTime":"0","endTime":"0","summary":"Oragenics published its FY 2025 Form 10-K annual report, reporting a net loss of USD 9.84 million. Research and development expense fell 41.85% to USD 2.39 million, primarily due to reduced nonclinical and contract research activity and wind-down costs tied to discontinued vaccine and antibiotic programs. General and administrative expense rose 8.15% to USD 6.97 million, driven mainly by higher patent expenses and increased investor relations and legal and professional fees. Oragenics ended FY 2025 with USD 8.4 million in cash and cash equivalents and said it expects this to fund its operating plan through the third quarter of 2026. The company said its lead program ONP-002 remains its focus, with a Phase 2a clinical trial expected to start in Q1 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nNDLCsJWg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618134281","title":"Oragenics completes first Phase IIa ONP-002 trial site initiation visit in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2618134281","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618134281?lang=en_us&edition=fundamental","pubTime":"2026-03-12 20:32","pubTimestamp":1773318723,"startTime":"0","endTime":"0","summary":"Completed the first site initiation visit for a Phase IIa trial of ONP-002 in Australia, with site staff training, protocol orientation, and site regulatory documentation completed.Two additional Australian trial sites remained in Research Governance Office final review after Human Research Ethics Committee approval, prior to activation for enrollment and dosing.The randomized, placebo-controlled Phase IIa study targets enrollment of 40 patients across three Australian clinical sites.The trial’s dosing window calls for the first dose to be administered within 12 hours of concussion onset.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oragenics Inc. published the original content used to generate this news brief on March 12, 2026, and ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nNDL6v7rt5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618613441","title":"Oragenics Initiates Phase Iia Clinical Trial Site Activation","url":"https://stock-news.laohu8.com/highlight/detail?id=2618613441","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618613441?lang=en_us&edition=fundamental","pubTime":"2026-03-12 20:30","pubTimestamp":1773318602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nTUA1V94GH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","OGEN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":44,"code":"91000000","status":"200"}]}}